Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2,314.37% | 0.03% | 98.85% | -470.47% | -59.31% |
| Total Depreciation and Amortization | 9.70% | 8.28% | -10.60% | -1.33% | 13.83% |
| Total Amortization of Deferred Charges | 5.42% | -41.39% | -69.83% | 305.22% | -68.45% |
| Total Other Non-Cash Items | 124.30% | 271.63% | -109.79% | 3,884.66% | 156.45% |
| Change in Net Operating Assets | -123.16% | 115.00% | 130.02% | -447.90% | 682.87% |
| Cash from Operations | -48.80% | 334.63% | 271.77% | -190.24% | 15,902.44% |
| Capital Expenditure | -10.57% | 23.88% | -188.81% | 128.71% | 6.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 105.36% | -- |
| Divestitures | 149.21% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.95% | -73.12% | -184.72% | 123.92% | -17.90% |
| Total Debt Issued | 45.39% | -26.85% | -27.47% | 213.49% | -88.66% |
| Total Debt Repaid | -42.05% | 62.32% | 11.23% | -71.45% | 49.87% |
| Issuance of Common Stock | 385.58% | -96.73% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.43% | -- | -- | 46.70% | 38.61% |
| Cash from Financing | 64.59% | -120.91% | 245.29% | 8.47% | -243.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.51% | 34.95% | 265.90% | 18.61% | -7,111.19% |
